{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:37:29Z","timestamp":1793633849339,"version":"4.5.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science Foundation of traditional Chinese medicine administration of Guangdong Province","award":["20221210"],"award-info":[{"award-number":["20221210"]}]},{"name":"Medical Scientific Research Foundation of Guangdong Province","award":["A2021243"],"award-info":[{"award-number":["A2021243"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102727"],"award-info":[{"award-number":["82102727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PhD Start-up Foundation of Guangdong Medical University","award":["GDMUB2020020"],"award-info":[{"award-number":["GDMUB2020020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04661-3","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:49:01Z","timestamp":1761875341000},"page":"5205-5221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["5-Methoxyflavone inhibits the proliferation of lung adenocarcinoma cells through PI3K\/AKT\/GSK3\u03b2\/\u03b2-catenin\/Cyclin D1 signaling and attenuates chemoresistance and PD-L1 expression"],"prefix":"10.1007","volume":"399","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"4661_CR1","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1101\/gad.854900","volume":"14","author":"JR Alt","year":"2000","unstructured":"Alt JR, Cleveland JL, Hannink M, Diehl JA (2000) Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14:3102\u20133114. https:\/\/doi.org\/10.1101\/gad.854900","journal-title":"Genes Dev"},{"key":"4661_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"BC Bade","year":"2020","unstructured":"Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41:1\u201324. https:\/\/doi.org\/10.1016\/j.ccm.2019.10.001","journal-title":"Clin Chest Med"},{"key":"4661_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L et al (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373:1627\u20131639. https:\/\/doi.org\/10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"key":"4661_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4661_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3978\/j.issn.2218-6751.2014.05.01","volume":"4","author":"BA Chan","year":"2015","unstructured":"Chan BA, Hughes BG (2015) Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 4:36\u201354. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2014.05.01","journal-title":"Transl Lung Cancer Res"},{"key":"4661_CR6","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499\u20133511. https:\/\/doi.org\/10.1101\/gad.12.22.3499","journal-title":"Genes Dev"},{"key":"4661_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2017.00066","volume":"8","author":"LC Dieterich","year":"2017","unstructured":"Dieterich LC, Ikenberg K, Cetintas T, Kapaklikaya K, Hutmacher C, Detmar M (2017) Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation. Front Immunol 8:66. https:\/\/doi.org\/10.3389\/fimmu.2017.00066","journal-title":"Front Immunol"},{"key":"4661_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.6004\/jnccn.2021","volume":"19","author":"DS Ettinger","year":"2021","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D\u2019Amico TA, Dilling TJ, Dowell J, Gettinger S, Gubens MA, Hegde A, Hennon M, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Lovly CM, Martins RG, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Riely GJ, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Yanagawa J, Yang SC, Gregory KM, Hughes M (2021) NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw 19:254\u2013266. https:\/\/doi.org\/10.6004\/jnccn.2021","journal-title":"J Natl Compr Canc Netw"},{"key":"4661_CR9","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1200\/JCO.19.00934","volume":"37","author":"EB Garon","year":"2019","unstructured":"Garon EB, Hellmann MD, Rizvi NA et al (2019) Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study. J Clin Oncol 37:2518\u20132527. https:\/\/doi.org\/10.1200\/JCO.19.00934","journal-title":"J Clin Oncol"},{"key":"4661_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12609-017-0232-0","volume":"9","author":"AC Garrido-Castro","year":"2017","unstructured":"Garrido-Castro AC, Goel S (2017) CDK4\/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure. Curr Breast Cancer Rep 9:26\u201333. https:\/\/doi.org\/10.1007\/s12609-017-0232-0","journal-title":"Curr Breast Cancer Rep"},{"key":"4661_CR11","doi-asserted-by":"publisher","unstructured":"Gettinger S, Horn L, Jackman D et al (2018) Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study. J Clin Oncol 36:1675\u20131684. https:\/\/doi.org\/10.1200\/JCO.2017.77.0412","DOI":"10.1200\/JCO.2017.77.0412"},{"key":"4661_CR12","doi-asserted-by":"publisher","unstructured":"He J, Huang Z, Han L, Gong Y, Xie C (2021) Mechanisms and management of 3rd\u2011generation EGFR\u2011TKI resistance in advanced non\u2011small cell lung cancer (Review). Int J Oncol 59:90. https:\/\/doi.org\/10.3892\/ijo.2021.5270","DOI":"10.3892\/ijo.2021.5270"},{"key":"4661_CR13","doi-asserted-by":"publisher","unstructured":"Herrera-Abreu MT, Palafox M, Asghar U et al (2016) Early Adaptation and Acquired Resistance to CDK4\/6 Inhibition in Estrogen Receptor-Positive Breast Cancer. Cancer Res 76:2301\u20132313.\u00a0https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0728","DOI":"10.1158\/0008-5472.CAN-15-0728"},{"key":"4661_CR14","doi-asserted-by":"publisher","unstructured":"Imielinski M, Berger AH, Hammerman PS et al (2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150:1107\u20131120.\u00a0https:\/\/doi.org\/10.1016\/j.cell.2012.08.029","DOI":"10.1016\/j.cell.2012.08.029"},{"key":"4661_CR15","doi-asserted-by":"publisher","unstructured":"Kang DY, Sp N, Lee JM, Jang KJ (2021) Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3\/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells. Biomedicines 9:297. https:\/\/doi.org\/10.3390\/biomedicines9030297","DOI":"10.3390\/biomedicines9030297"},{"key":"4661_CR16","doi-asserted-by":"publisher","unstructured":"Koirala N, Thuan NH, Ghimire GP, Thang DV, Sohng JK (2016) Methylation of flavonoids: Chemical structures, bioactivities, progress and perspectives for biotechnological production. Enzyme Microb Technol 86:103\u2013116. https:\/\/doi.org\/10.1016\/j.enzmictec.2016.02.003","DOI":"10.1016\/j.enzmictec.2016.02.003"},{"key":"4661_CR17","doi-asserted-by":"publisher","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E (2021) Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy. Int J Mol Sci 22:8885. https:\/\/doi.org\/10.3390\/ijms22168885","DOI":"10.3390\/ijms22168885"},{"key":"4661_CR18","doi-asserted-by":"publisher","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, Mukherjee A, Paul MK (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer 22:40. https:\/\/doi.org\/10.1186\/s12943-023-01740-y","DOI":"10.1186\/s12943-023-01740-y"},{"key":"4661_CR19","doi-asserted-by":"publisher","unstructured":"Li JP, Liao XH, Xiang Y, Yao A, Song RH, Zhang ZJ, Huang F, Dai ZT, Zhang TC (2018) Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1\/S phase arrest. Gene 679:232\u2013240. https:\/\/doi.org\/10.1016\/j.gene.2018.09.011","DOI":"10.1016\/j.gene.2018.09.011"},{"key":"4661_CR20","doi-asserted-by":"publisher","unstructured":"Li K, Gao S, Ma L, Sun Y, Peng ZY, Wu J, Du N, Ren H, Tang SC, Sun X (2021) Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner. Front Oncol 11:731561. https:\/\/doi.org\/10.3389\/fonc.2021.731561","DOI":"10.3389\/fonc.2021.731561"},{"key":"4661_CR21","doi-asserted-by":"publisher","unstructured":"Li K, Peng ZY, Gao S, Wang QS, Wang R, Li X, Xiao GD, Zhang J, Ren H, Tang SC, Sun X (2021) M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way. J Exp Clin Cancer Res 40:325. https:\/\/doi.org\/10.1186\/s13046-021-02137-9","DOI":"10.1186\/s13046-021-02137-9"},{"key":"4661_CR22","doi-asserted-by":"publisher","unstructured":"Li Y, Xu Z, Wang S, Zhu Y, Ma D, Mu Y, Ying J, Li J, Xing P (2022) Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA. Thorac Cancer 13:2201\u20132209. https:\/\/doi.org\/10.1111\/1759-7714.14545","DOI":"10.1111\/1759-7714.14545"},{"key":"4661_CR23","doi-asserted-by":"publisher","unstructured":"Liang P, Wang L, Yang S, Pan X, Li J, Zhang Y, Liang Y, Li J, Zhou B (2022) 5-Methoxyflavone alleviates LPS-mediated lung injury by promoting Nrf2-mediated the suppression of NOX4\/TLR4 axis in bronchial epithelial cells\u00a0and M1 polarization in macrophages. J Inflamm (Lond) 19:24.\u00a0https:\/\/doi.org\/10.1186\/s12950-022-00319-6","DOI":"10.1186\/s12950-022-00319-6"},{"key":"4661_CR24","doi-asserted-by":"publisher","unstructured":"Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA (2006) Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell 24:355\u2013366. https:\/\/doi.org\/10.1016\/j.molcel.2006.09.007","DOI":"10.1016\/j.molcel.2006.09.007"},{"key":"4661_CR25","doi-asserted-by":"publisher","unstructured":"Lin Z, Lin Y, Shen J, Jiang M, Hou Y (2020) Flavonoids in Ageratum conyzoides L. Exert Potent Antitumor Effects on Human Cervical Adenocarcinoma HeLa Cells In Vitro and In Vivo. Biomed Res Int 2020:2696350.\u00a0https:\/\/doi.org\/10.1155\/2020\/2696350","DOI":"10.1155\/2020\/2696350"},{"key":"4661_CR26","doi-asserted-by":"publisher","unstructured":"Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K (2018) EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer 17:53. https:\/\/doi.org\/10.1186\/s12943-018-0793-1","DOI":"10.1186\/s12943-018-0793-1"},{"key":"4661_CR27","doi-asserted-by":"publisher","unstructured":"Lu C, Wang H, Chen S, Yang R, Li H, Zhang G (2018) Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN\/PI3K\/Akt pathway. J Cell Mol Med 22:2478\u20132487.https:\/\/doi.org\/10.1111\/jcmm.13556","DOI":"10.1111\/jcmm.13556"},{"key":"4661_CR28","doi-asserted-by":"publisher","unstructured":"Lv C, Qin W, Zhu T, Wei S, Hong K, Zhu W, Chen R, Huang C (2015) Ophiobolin O isolated from Aspergillus ustus induces G1 arrest of MCF-7 cells through interaction with AKT\/GSK3\u03b2\/cyclin D1 signaling. Mar Drugs 13:431\u2013443. https:\/\/doi.org\/10.3390\/md13010431","DOI":"10.3390\/md13010431"},{"key":"4661_CR29","doi-asserted-by":"publisher","unstructured":"Ma L, Diao B, Huang Z, Wang B, Yu J, Meng X (2021) The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutation. Cancer Commun (Lond) 41:1314\u20131330. https:\/\/doi.org\/10.1002\/cac2.12229","DOI":"10.1002\/cac2.12229"},{"key":"4661_CR30","doi-asserted-by":"publisher","unstructured":"Maleki SJ, Crespo JF, Cabanillas B (2019) Anti-inflammatory effects of flavonoids. Food Chem 299:125124. https:\/\/doi.org\/10.1002\/cac2.12229","DOI":"10.1002\/cac2.12229"},{"key":"4661_CR31","doi-asserted-by":"publisher","unstructured":"Mimura K, Teh JL, Okayama H, Shiraishi K, Kua LF, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, Fazreen Z, Asuncion BR, Shabbir A, Yong WP, So J, Soong R, Kono K (2018) PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci 109:43\u201353. https:\/\/doi.org\/10.1111\/cas.13424","DOI":"10.1111\/cas.13424"},{"key":"4661_CR32","doi-asserted-by":"publisher","unstructured":"Mondal P, Meeran SM (2023) Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer. Front Pharmacol 14:1105484.\u00a0https:\/\/doi.org\/10.3389\/fphar.2023.1105484","DOI":"10.3389\/fphar.2023.1105484"},{"key":"4661_CR33","doi-asserted-by":"publisher","unstructured":"Navaei ZN, Khalili-Tanha G, Zangouei AS, Abbaszadegan MR, Moghbeli M (2022) PI3K\/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. Oncol Res 29:235\u2013250. https:\/\/doi.org\/10.32604\/or.2022.025323","DOI":"10.32604\/or.2022.025323"},{"key":"4661_CR34","doi-asserted-by":"publisher","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S (2014) PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 211:781\u2013790.\u00a0https:\/\/doi.org\/10.1084\/jem.20131916","DOI":"10.1084\/jem.20131916"},{"key":"4661_CR35","doi-asserted-by":"publisher","unstructured":"Oh S, Kim H, Nam K, Shin I (2017) Silencing of Glut1 induces chemoresistance via modulation of AKT\/GSK-3beta\/beta-catenin\/survivin signaling pathway in breast cancer cells. Archives of Biochemistry and Biophysics 636:110\u2013122.https:\/\/doi.org\/10.1016\/j.abb.2017.08.009","DOI":"10.1016\/j.abb.2017.08.009"},{"key":"4661_CR36","doi-asserted-by":"publisher","unstructured":"Rugamba A, Kang DY, Sp N, Jo ES, Lee JM, Bae SW, Jang KJ (2021) Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. Cells 10:1632. https:\/\/doi.org\/10.3390\/cells10071632","DOI":"10.3390\/cells10071632"},{"key":"4661_CR37","doi-asserted-by":"publisher","unstructured":"Sherr CJ, Beach D, Shapiro GI (2016) Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov 6:353\u2013367. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0894","DOI":"10.1158\/2159-8290.CD-15-0894"},{"key":"4661_CR38","doi-asserted-by":"publisher","unstructured":"Shin SY, Hyun J, Yu JR, Lim Y, Lee YH (2011) 5-Methoxyflavanone induces cell cycle arrest at the G2\/M phase, apoptosis and autophagy in HCT116 human colon cancer cells. Toxicol Appl Pharmacol 254:288\u2013298.https:\/\/doi.org\/10.1016\/j.taap.2011.05.003","DOI":"10.1016\/j.taap.2011.05.003"},{"key":"4661_CR39","doi-asserted-by":"publisher","unstructured":"Song M, Bode AM, Dong Z, Lee MH (2019) AKT as a Therapeutic Target for Cancer. Cancer Res 79:1019\u20131031. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2738","DOI":"10.1158\/0008-5472.CAN-18-2738"},{"key":"4661_CR40","doi-asserted-by":"publisher","unstructured":"Song M, Cui M, Liu K (2022) Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. Eur J Med Chem 232:114205. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114205","DOI":"10.1016\/j.ejmech.2022.114205"},{"key":"4661_CR41","doi-asserted-by":"publisher","unstructured":"Song TL, Nairism\u00e4gi ML, Laurensia Y, Lim JQ, Tan J, Li ZM, Pang WL, Kizhakeyil A, Wijaya GC, Huang DC, Nagarajan S, Chia BK, Cheah D, Liu YH, Zhang F, Rao HL, Tang T, Wong EK, Bei JX, Iqbal J, Grigoropoulos NF, Ng SB, Chng WJ, Teh BT, Tan SY, Verma NK, Fan H, Lim ST, Ong CK (2018) Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma. Blood 132(11):1146\u20131158.\u00a0https:\/\/doi.org\/10.1182\/blood-2018-01-829424","DOI":"10.1182\/blood-2018-01-829424"},{"key":"4661_CR42","doi-asserted-by":"publisher","unstructured":"Takke A, Shende P (2019) Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine 21:102057.\u00a0https:\/\/doi.org\/10.1016\/j.nano.2019.102057","DOI":"10.1016\/j.nano.2019.102057"},{"key":"4661_CR43","doi-asserted-by":"publisher","unstructured":"Tan AC (2020) Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer 11:511\u2013518. https:\/\/doi.org\/10.1111\/1759-7714.13328","DOI":"10.1111\/1759-7714.13328"},{"key":"4661_CR44","doi-asserted-by":"publisher","unstructured":"Tan BJ, Liu Y, Chang KL, Lim BK, Chiu GN (2012) Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int J Nanomedicine 7:651\u2013661. https:\/\/doi.org\/10.2147\/IJN.S26538","DOI":"10.2147\/IJN.S26538"},{"key":"4661_CR45","doi-asserted-by":"publisher","unstructured":"Taube JM, Anders RA, Young GD, Xu H, Sharma R, McMiller TL, Chen S, Klein AP, Pardoll DM, Topalian SL, Chen L (2012) Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci Transl Med 4:127ra37.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.3003689","DOI":"10.1126\/scitranslmed.3003689"},{"key":"4661_CR46","doi-asserted-by":"publisher","unstructured":"Teng H, Zheng Y, Cao H, Huang Q, Xiao J, Chen L (2023) Enhancement of bioavailability and bioactivity of diet-derived flavonoids by application of nanotechnology: a review. Crit Rev Food Sci Nutr 63:378\u2013393.\u00a0https:\/\/doi.org\/10.1080\/10408398.2021.1947772","DOI":"10.1080\/10408398.2021.1947772"},{"key":"4661_CR47","doi-asserted-by":"publisher","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108.\u00a0https:\/\/doi.org\/10.3322\/caac.21262","DOI":"10.3322\/caac.21262"},{"key":"4661_CR48","doi-asserted-by":"publisher","unstructured":"Tronina T, \u0141u\u017cny M, Dymarska M, Urbaniak M, Koz\u0142owska E, Piegza M, St\u0119pie\u0144 \u0141, Janeczko T (2023). Glycosylation of Quercetin by Selected Entomopathogenic Filamentous Fungi and Prediction of Its Products' Bioactivity. Int J Mol Sci 24:11857. https:\/\/doi.org\/10.3390\/ijms241411857","DOI":"10.3390\/ijms241411857"},{"key":"4661_CR49","doi-asserted-by":"publisher","unstructured":"van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901\u201317905.\u00a0https:\/\/doi.org\/10.1074\/jbc.M111635200","DOI":"10.1074\/jbc.M111635200"},{"key":"4661_CR50","doi-asserted-by":"publisher","unstructured":"Verdura S, Cuy\u00e0s E, Ruiz-Torres V, Micol V, Joven J, Bosch-Barrera J, Menendez JA (2021) Lung Cancer Management with Silibinin: A Historical and Translational Perspective. Pharmaceuticals (Basel) 14:559.\u00a0https:\/\/doi.org\/10.3390\/ph14060559","DOI":"10.3390\/ph14060559"},{"key":"4661_CR51","doi-asserted-by":"publisher","unstructured":"Wang J, Li XM, Bai Z, Chi BX, Wei Y, Chen X (2018) Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt\/ GSK3\u03b2\/cyclin D1 pathway. J Ethnopharmacol 210:1\u20139.\u00a0https:\/\/doi.org\/10.1016\/j.jep.2017.06.037","DOI":"10.1016\/j.jep.2017.06.037"},{"key":"4661_CR52","doi-asserted-by":"publisher","unstructured":"W\u00f6lfle SJ, Strebovsky J, Bartz H, S\u00e4hr A, Arnold C, Kaiser C, Dalpke AH, Heeg K (2011) PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur J Immunol 41:413\u2013424.\u00a0https:\/\/doi.org\/10.1002\/eji.201040979","DOI":"10.1002\/eji.201040979"},{"key":"4661_CR53","doi-asserted-by":"publisher","unstructured":"Wu L, Yang W, Zhang SN, Lu JB (2015) Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium. Drug Des Devel Ther 9:6119\u20136127. https:\/\/doi.org\/10.2147\/DDDT.S92702","DOI":"10.2147\/DDDT.S92702"},{"key":"4661_CR54","doi-asserted-by":"publisher","unstructured":"Xie C, Zhou X, Liang C, Li X, Ge M, Chen Y, Yin J, Zhu J, Zhong C (2021) Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer. J Exp Clin Cancer Res 40:266. https:\/\/doi.org\/10.1186\/s13046-021-02069-4","DOI":"10.1186\/s13046-021-02069-4"},{"key":"4661_CR55","doi-asserted-by":"publisher","unstructured":"Yamaoka T, Kusumoto S, Ando K, Ohba M, Ohmori T (2018) Receptor Tyrosine Kinase-Targeted Cancer Therapy. Int J Mol Sci 19:3491.\u00a0https:\/\/doi.org\/10.3390\/ijms19113491","DOI":"10.3390\/ijms19113491"},{"key":"4661_CR56","doi-asserted-by":"publisher","unstructured":"Yip H, Papa A (2021) Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. Cells 10:659.\u00a0https:\/\/doi.org\/10.3390\/cells10030659","DOI":"10.3390\/cells10030659"},{"key":"4661_CR57","doi-asserted-by":"publisher","unstructured":"Yu M, Qi B, Xiaoxiang W, Xu J, Liu X (2017) Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K\/Akt\/NF-\u03baB pathway. Biomed Pharmacother 90:677\u2013685.\u00a0https:\/\/doi.org\/10.1016\/j.biopha.2017.04.001","DOI":"10.1016\/j.biopha.2017.04.001"},{"key":"4661_CR58","doi-asserted-by":"publisher","unstructured":"Zappa C, Mousa SA (2016) Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res 5:288\u2013300.\u00a0https:\/\/doi.org\/10.21037\/tlcr.2016.06.07","DOI":"10.21037\/tlcr.2016.06.07"},{"key":"4661_CR59","doi-asserted-by":"publisher","unstructured":"Zhang M, Wang R, Tian J, Song M, Zhao R, Liu K, Zhu F, Shim JH, Dong Z, Lee MH (2021) Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo. J Cell Mol Med 25:5560\u20135571.\u00a0https:\/\/doi.org\/10.1111\/jcmm.16568","DOI":"10.1111\/jcmm.16568"},{"key":"4661_CR60","doi-asserted-by":"publisher","unstructured":"Zhang Y, Fu Q, Wu T, Liu K, Xiao Y, Liao Q, Qi X, Li Y, Zhou L (2023) 5-Methoxyflavone ameliorates non-alcoholic fatty liver disease through targeting the cytochrome P450 1A1. Free Radic Biol Med 195:178\u2013191.\u00a0https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.12.093","DOI":"10.1016\/j.freeradbiomed.2022.12.093"},{"key":"4661_CR61","doi-asserted-by":"publisher","unstructured":"Zhao F, Zhao Z, Han Y, Li S, Liu C, Jia K (2021) Baicalin suppresses lung cancer growth phenotypes via miR-340-5p\/NET1 axis. Bioengineered 12:1699\u20131707.\u00a0https:\/\/doi.org\/10.1080\/21655979.2021.1922052","DOI":"10.1080\/21655979.2021.1922052"},{"key":"4661_CR62","doi-asserted-by":"publisher","unstructured":"Zhao X, Chen R, Shi Y, Zhang X, Tian C, Xia D (2020) Antioxidant and Anti-Inflammatory Activities of Six Flavonoids from Smilax glabra Roxb. Molecules 25:5295.\u00a0https:\/\/doi.org\/10.3390\/molecules25225295","DOI":"10.3390\/molecules25225295"},{"key":"4661_CR63","doi-asserted-by":"publisher","unstructured":"Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L (2020) The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. Front Pharmacol 11:343. https:\/\/doi.org\/10.3389\/fphar.2020.00343","DOI":"10.3389\/fphar.2020.00343"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04661-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04661-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04661-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:06:47Z","timestamp":1775099207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04661-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4661"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04661-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Institutional Animal\u00a0Care and Use Committee of the Guangdong Medical University\u00a0(Approval No.: GDMU-2023-000117).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}